Seeking Alpha

Optimer Pharmaceuticals (OPTR): Q4 EPS of $0.29 may not be comparable to consensus of $0.51....

Optimer Pharmaceuticals (OPTR): Q4 EPS of $0.29 may not be comparable to consensus of $0.51. Revenue of $64.6M beats by $21M. Shares +0.9% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)